However, in regard to PXR, differential tissue-specific expression of the protein, and its co-regulators may play a significant role in drug bioavailability in non-neoplastic versus neoplastic tissues, as well as modulation of the drug’s mechanism of action at tumor sites. This evidence concerns the gene NR1I2 and neoplasm.